Equasens: 2023 revenue: €219.7m, +2.6%
February 06, 2024 12:00 ET
|
EQUASENS
Villers-lès-Nancy, 6 February 2024 - 6:00 p.m. (CET) PRESS RELEASE 2023 revenue: €219.7m, +2.6% Equasens Group reported growth in annual revenue, despite an unfavourable comparison base from the...
EQUASENS : Prise de participation majoritaire dans DIGIPHARMACIE
January 02, 2024 12:00 ET
|
EQUASENS
Villers-lès-Nancy, le 2 janvier 2024 – 18:00 (CET) COMMUNIQUE DE PRESSE Prise de participation majoritaire dans DIGIPHARMACIE, Expert en digitalisation et gestion des factures en pharmacie Avec...
Equasens: Acquisition of a majority stake in DIGIPHARMACIE
January 02, 2024 12:00 ET
|
EQUASENS
Villers-lès-Nancy, 2 January 2024 - 6:00 p.m. (CET) PRESS RELEASE Acquisition of a majority stake in DIGIPHARMACIE, An expert in digital and invoice management solutions for pharmacies With this...
EQUASENS : Evolution du Comité de Direction du Groupe Equasens
December 27, 2023 12:00 ET
|
EQUASENS
Villers-lès-Nancy, le 27 décembre 2023 – 18:00 (CET)COMMUNIQUE DE PRESSE Evolution du Comité de Direction du Groupe Equasens Le Groupe Equasens, éditeur leader en logiciel santé (Euronext Paris™ -...
Equasens: Changes in the Equasens Group Executive Committee
December 27, 2023 12:00 ET
|
EQUASENS
Villers-lès-Nancy, 27 December 2023 - 6:00 p.m. (CET)PRESS RELEASE Changes in the Equasens Group Executive Committee Equasens Group, a leading healthcare software publisher (Euronext Paris™ -...
Truveta welcomes Patrick Caubel, Pfizer Chief Safety Officer, to its Board of Directors
December 04, 2023 09:00 ET
|
Truveta
BELLEVUE, Wash., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Truveta, the company with a mission of saving lives with data, welcomes its first member from the life science industry to its Board of Directors....
EQUASENS : Acquisition de l’allemand ADV et naissance de PHARMAGEST Germany
November 23, 2023 12:00 ET
|
EQUASENS
Villers-lès-Nancy, le 23 novembre 2023 – 18:00 (CET) COMMUNIQUE DE PRESSE Acquisition de l’allemand ADV et naissance de PHARMAGEST Germany EQUASENS, en association avec ARZ HAAN, un des leaders sur...
EQUASENS: Acquisition of the German company ADV and creation of PHARMAGEST Germany
November 23, 2023 12:00 ET
|
EQUASENS
Villers-lès-Nancy, 23 November 2023 - 6:00 p.m. (CET) PRESS RELEASE Acquisition of the German company ADVand creation of PHARMAGEST Germany EQUASENS, in partnership with ARZ HAAN, a German market...
EQUASENS : Chiffre d’affaires du 3ème trimestre 2023
November 09, 2023 12:00 ET
|
EQUASENS
Villers-lès-Nancy, le 9 novembre 2023 - 18h00 (CET) COMMUNIQUE DE PRESSE Chiffre d’affaires du 3ème trimestre 2023 Chiffre d’affaires du T3 2023 : stable comparée au T3 2022 à 50,1 M€La...
Equasens: Q3 2023 revenue
November 09, 2023 12:00 ET
|
EQUASENS
Villers-lès-Nancy, 9 November 2023 - 6:00 p.m. (CET) PRESS RELEASE Q3 2023 revenue Q3 2023 revenue: stable year-on-year at €50.1mGrowth impacted by: The completed deployment of solutions under...